Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner
2003 National Healthcare Quality Report

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Infection due to intravenous lines or catheters and infection due to intravenous lines or catheters (area).

Measure Source

Agency for Healthcare Research and Quality (AHRQ) Patient Safety Indicators.

Tables

2.10a Infection due to intravenous lines or catheters per 1,000 discharges (excluding immunocompromised or cancer patients and neonates; based on secondary diagnoses only), by patient and hospital characteristics, United States, 2000.

2.10b Infection due to intravenous lines or catheters (excluding immunocompromised or cancer patients and neonates; based on principal and secondary diagnoses) per 100,000 population, by patient and hospital characteristics, United States, 2000.

Data Source

Agency for Healthcare Research and Quality, Center for Delivery, Organization, and Markets, Healthcare Cost and Utilization Project (HCUP), Nationwide Inpatient Sample.

Denominator

Table 2.10a: All non-neonatal medical and surgical hospital discharges, excluding immunocompromised or cancer patients.

Table 2.10b: U. S. population.

Numerator

Table 2.10a: All non-neonatal medical and surgical hospital discharges with any secondary diagnosis of infection (ICD-9-CM diagnosis code 999.3 or 996.62,) excluding immunocompromised or cancer patients.

Table 2.10b: All non-neonatal medical and surgical hospital discharges with any principal or secondary diagnosis of infection (ICD-9-CM diagnosis code 999.3 or 996.62,) excluding immunocompromised or cancer patients.

Comments

Rates are adjusted by age, gender, age-gender interactions, comorbidities, and DRG clusters. DRGs are Diagnosis Related Groups which identify patients with similar illnesses.

Although not all states participate in the HCUP database, it is weighted to give national estimates using weights based on all U.S. community, non-rehabilitation hospitals in the American Hospital Association Annual Survey of Hospitals.

These tables were created using a beta-test version of the AHRQ Patient Safety Indicators software dated July 2002 that differs from the AHRQ Patient Safety Indicators software currently available on the AHRQ Web site. These measures are referred to as indicator 7 (discharge-based) and 23 (area-based) in the AHRQ Patient Safety Indicators software documentation.

Return to Previous Measure
Return to Measures Specifications Appendix
Proceed to Next Measure
Return to Contents

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care